EDGAR Filing Documents for 0001213900-19-012456

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-19-012456

Filing Date

2019-07-10

Accepted

2019-07-10 17:26:43

Documents

Period of Report

2019-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	f10q0519_oramedpharma.htm	10-Q	431176
2	AMENDMENT #1 TO CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT PROTOCOL # ORA	f10q0519ex10-1_oramed.htm	EX-10.1	621803
3	AMENDMENT #2 TO CLINICAL RESEARCH ORGANIZATION SERVICES AGREEMENT PROTOCOL # ORA	f10q0519ex10-2_oramed.htm	EX-10.2	105288
4	EMPLOYMENT AGREEMENT, DATED MAY 16, 2019, BETWEEN ORAMED LTD. AND AVRAHAM GABAY	f10q0519ex10-3_oramed.htm	EX-10.3	151037
5	REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS	f10q0519ex10-4_oramed.htm	EX-10.4	88606
6	CERTIFICATION	f10q0519ex31-1_oramed.htm	EX-31.1	16182
7	CERTIFICATION	f10q0519ex31-2_oramed.htm	EX-31.2	16164
8	CERTIFICATION	f10q0519ex32-1_oramed.htm	EX-32.1	5274
9	CERTIFICATION	f10q0519ex32-2_oramed.htm	EX-32.2	7736
10	GRAPHIC	image_001.jpg	GRAPHIC	2367
11	GRAPHIC	image_002.jpg	GRAPHIC	2082
12	GRAPHIC	image_003.jpg	GRAPHIC	1673
	Complete submission text file	0001213900-19-012456.txt		3532596

Data Files

Seq	Description	Document	Type	Size
13	XBRL INSTANCE FILE	ormp-20190531.xml	EX-101.INS	400163
14	XBRL SCHEMA FILE	ormp-20190531.xsd	EX-101.SCH	29692
15	XBRL CALCULATION FILE	ormp-20190531_cal.xml	EX-101.CAL	40193
16	XBRL DEFINITION FILE	ormp-20190531_def.xml	EX-101.DEF	120329
17	XBRL LABEL FILE	ormp-20190531_lab.xml	EX-101.LAB	247716
18	XBRL PRESENTATION FILE	ormp-20190531_pre.xml	EX-101.PRE	176245

Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019

Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164

ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)